Cooper Companies (NASDAQ:COO – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided EPS guidance of 3.640-3.670 for the period, compared to the consensus EPS estimate of 3.570. The company issued revenue guidance of $3.9 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion. Cooper Companies also updated its Q4 guidance to $0.98-1.01 EPS.
Cooper Companies Stock Performance
Shares of NASDAQ COO traded up $0.19 during trading hours on Wednesday, reaching $94.54. The stock had a trading volume of 1,231,936 shares, compared to its average volume of 1,107,962. The firm has a 50-day moving average of $90.91 and a 200-day moving average of $94.03. The firm has a market cap of $18.82 billion, a price-to-earnings ratio of 55.61, a PEG ratio of 2.34 and a beta of 0.98. The company has a current ratio of 1.95, a quick ratio of 1.14 and a debt-to-equity ratio of 0.34. Cooper Companies has a fifty-two week low of $75.93 and a fifty-two week high of $104.07.
Cooper Companies (NASDAQ:COO – Get Free Report) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The company’s revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.84 earnings per share. Equities research analysts predict that Cooper Companies will post 3.57 earnings per share for the current year.
Analyst Ratings Changes
Cooper Companies Company Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Read More
- Five stocks we like better than Cooper Companies
- What is the Dogs of the Dow Strategy? Overview and Examples
- BHP Stock: The Under-the-Radar Growth Story in Commodities
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Analysts Upgrade These 3 Hot Buy-and-Hold Stocks
- How to Invest in the Best Canadian StocksÂ
- Kohl’s Charts a Resilient Path in a Challenging Retail Landscape
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.